阿卡迪亞製藥公司
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership19,878,746 shares
Ownership 11.90%
BlackRock, Inc. ownership in ACAD / ACADIA Pharmaceuticals Inc.

2025-02-07 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 19,878,746 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD). This represents 11.9 percent ownership of the company. In their previous filing dated 2024-01-26 , BlackRock, Inc. had reported owning 11,409,218 shares, indicating an increase of 74.23 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2025-02-07 2025-02-07 13G/A 11,409,218 19,878,746 74.23 11.90 72.46
2024-01-26 2024-01-26 13G/A 10,258,738 11,409,218 11.21 6.90 9.52
2023-02-01 2023-02-01 13G/A 10,060,312 10,258,738 1.97 6.30 0.00
2022-02-04 2022-02-04 13G 7,757,846 10,060,312 29.68 6.30 26.76
2020-07-10 2020-07-10 13G/A 10,238,895 7,757,846 -24.23 4.97 -24.70
2020-02-05 2020-02-05 13G/A 10,133,466 10,238,895 1.04 6.60 -8.33
2019-02-04 2019-02-04 13G/A 6,710,697 10,133,466 51.00 7.20 33.33
2018-02-01 2018-02-01 13G 4,757,952 6,710,697 41.04 5.40 28.57
2016-07-08 2016-07-08 13G/A 5,847,357 4,757,952 -18.63 4.20 -27.59
2016-01-25 2016-01-25 13G/A 5,847,357 5.80
2015-02-02 2015-02-02 13G/A 5,581,281 5.60
2014-01-28 2014-01-28 13G 5,556,789 6.10

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 21,550,921 795,469 3.83 479,724 -13.47 0.0084
2026-02-12 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 20,755,452 486,808 2.40 554,378 28.17 0.0094
2025-11-12 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 20,268,644 -383,772 -1.86 432,533 -2.90 0.0076
2025-08-12 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 20,652,416 -714,141 -3.34 445,473 25.52 0.0085
2025-05-02 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 21,366,557 8,636,698 67.85 354,899 51.93 0.0075
2025-02-07 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 12,729,859 -64,962 -0.51 233,593 18.70 0.0047
2024-11-13 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 12,794,821 732,608 6.07 196,784 0.39 0.0041
2024-08-13 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 12,062,213 393,473 3.37 196,011 -9.15 0.0044
2024-05-10 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 11,668,740 258,257 2.26 215,755 -39.61 0.0050
2024-02-13 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 11,410,483 1,381,898 13.78 357,262 70.94 0.0091
2023-11-13 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 10,028,585 -10,916 -0.11 208,996 -13.08 0.0060
2023-08-11 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 10,039,501 170,370 1.73 240,446 29.46 0.0066
2023-05-12 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 9,869,131 -390,053 -3.80 185,737 13.72 0.0055
2023-02-13 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 10,259,184 286,029 2.87 163,326 0.10 0.0051
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 9,973,155 231,841 2.38 163,161 18.87 0.0055
2022-08-12 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 9,741,314 -228,709 -2.29 137,256 -43.16 0.0044
2022-05-12 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 9,970,023 -90,289 -0.90 241,472 2.84 0.0065
2022-02-10 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 10,060,312 -94,639 -0.93 234,810 39.21 0.0060
2021-11-09 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 10,154,951 15,748 0.16 168,673 -31.79 0.0047
2021-08-11 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 10,139,203 2,737,601 36.99 247,295 29.50 0.0069
2021-05-07 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 7,401,602 170,805 2.36 190,960 -50.60 0.0056
2021-02-05 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 7,230,797 69,586 0.97 386,560 30.86 0.0123
2020-11-06 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 7,161,211 -596,635 -7.69 295,400 -21.44 0.0109
2020-08-14 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 7,757,846 -2,378,264 -23.46 376,022 -12.20 0.0150
2020-05-01 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 10,136,110 -102,785 -1.00 428,249 -2.23 0.0209
2020-02-13 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 10,238,895 709,570 7.45 438,020 27.72 0.0168
2019-11-08 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 9,529,325 -124,239 -1.29 342,960 32.91 0.0144
2019-08-22 2019-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 9,653,564 -1,065,144 -9.94 258,040 -10.34 0.0110
2019-08-13 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 9,653,564 -1,065,144 258,040
2019-05-09 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 10,718,708 585,242 5.78 287,799 75.64 0.0128
2019-02-08 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 10,133,466 346,561 3.54 163,859 -19.35 0.0083
2018-11-09 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 9,786,905 51,804 0.53 203,175 36.68 0.0088
2018-08-09 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 9,735,101 3,085,874 46.41 148,654 -0.50 0.0068
2018-05-09 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 6,649,227 -61,470 -0.92 149,407 -26.06 0.0071
2018-02-09 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 6,710,697 321,950 5.04 202,060 -16.04 0.0096
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 6,388,747 798,041 14.27 240,664 54.35 0.0121
2017-08-10 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 5,590,706 157,497 2.90 155,925 -16.52 0.0083
2017-05-12 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 5,433,209 5,334,832 5,422.84 186,791 6,484.10 0.0103
2017-02-10 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 98,377 84,906 630.29 2,837 562.85 0.0040
2016-11-08 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 13,471 1,094 8.84 428 6.73 0.0006
2016-08-10 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 12,377 6,963 128.61 401 163.82 0.0006
2016-05-10 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 5,414 3,153 139.45 152 87.65 0.0002
2016-02-11 2015-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,261 542 31.53 81 42.11 0.0001
2015-11-13 2015-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,719 -337 -16.39 57 -33.72 0.0001
2015-08-07 2015-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,056 -22 -1.06 86 26.47 0.0001
2015-05-13 2015-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,078 0 0.00 68 3.03 0.0001
2015-02-09 2014-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,078 -330 -13.70 66 10.00 0.0001
2014-10-29 2014-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,408 0 0.00 60 9.09 0.0001
2014-08-06 2014-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,408 -103 -4.10 55 -9.84 0.0001
2014-05-02 2014-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,511 147 6.22 61 3.39 0.0001
2014-02-12 2013-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,364 0 0.00 59 -9.23 0.0001
2013-11-12 2013-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,364 -40,877 -94.53 65 -91.71 0.0001
2013-08-13 2013-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 43,241 43,241 784 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.